Molecular mechanisms of lymphangiogenesis

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 67, Issue , 2002, Pages 189-196

  Makinen T ^a   Alitalo, K ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOTENSIN I; CELL MARKER; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX 1; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3; PROX 1 PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BASEMENT MEMBRANE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; EMBRYO; EMBRYO DEVELOPMENT; FETUS; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHEDEMA; MESENCHYME; MISSENSE MUTATION; MOLECULAR DYNAMICS; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; TUMOR MODEL; VASCULAR ENDOTHELIUM; ARTICLE; BLOOD CELL; ENDOTHELIUM CELL; LYMPHATIC SYSTEM TUMOR; LYMPHATIC VESSEL TUMOR; VASCULAR ENDOTHELIAL CELL; VASCULARIZATION;

ANIMALIA; MUS MUSCULUS;

EID: 0038801374     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2002.67.189     Document Type: Conference Paper

References (65)

1. Alitaio K. and Carmeliet P. 2002. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1: 219.
2. Ayadi A., Zheng H., Sobieszczuk P., Buchwalter G., Moerman P.,m alitalo K., and Wasylyk B. 2001 Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J. 20: 5139.
3. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., and Jackson D.G. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144: 789.
4. Beltramo E., Pomero F., Allione A., D'Alu F., Ponte E., and Porta M. 2002. Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 45: 416.
5. Benjamin L.E., Hemo I., and Keshet E. 1998. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591.
6. Bi W., Drake C.J., and Schwarz J.J. 1999. The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev. Biol. 211: 255.
7. Biedermann B.C. 2001. Vascular endothelium: Checkpoint for inflammation and immunity. News Physiol. Sci. 16: 84.
8. Breiteneder-Geleff S., Soleiman A., Kowalski H., Horvat R., Amann G., Kriehuber E., Diem K., Weninger W., Tschachler E., Alitalo K., and Kerjaschki D. 1999. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am. J Pathol. 154: 385.
9. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6: 389.
10. Carmeliet P. and Jain R.K. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249.
11. Dumont D.J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., Breitman M., and Alitalo K. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946.
12. Ebata N., Nodasaka Y., Sawa Y., Yamaoka Y., Makino S., Totsuka Y., and Yoshida S. 2001. Desmoplakin as a specific marker of lymphatic vessels. Microvasc. Res. 61: 40-48.
13. Ferrara N. 1999. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77: 527.
14. Gale N.W., Thurston G., Hackett S.F., Renard R., Wang Q., McClain J., Martin C., Witte C., Witte M.H., Jackson D., Suri C., Campochiaro P.A., Wiegand S.J., and Yancopoulos G.D. 2002. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell 3: 411.
15. He Y., Kozaki K., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., and Alitalo K. 2002. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 5: 819.
16. Hosking B.M., Wang S.C., Chen S.L., Penning S., Koopman P., and Muscat G.E. 2001. SOX18 directly interacts with MEF2C in endothelial cells. Biochem. Biophys. Res. Commun. 287: 493.
17. Huang X.Z., Wu J.F., Ferrando R., Lee J.H., Wang Y.L, Farese R.V., Jr., and Sheppard D. 2000. Fatal bilateral chylothorax in mice lacking the integrin α9β1. Mol. Cell. Biol. 20: 5208.
18. Huntington G.S. and McClure C.F.W. 1908. The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica). Anat. Rec. 2: 1.
19. Iljin K., Karkkainen M.J., Lawrence E.C., Kimak M.A., Uutela M., Taipale J., Pajusola K., Alhonen L., Halmekyto M., Finegold D.N., Ferrell R.E., and Alitalo K. 2001. VEGFR3 gene structure, regulatory region, and sequence polymorphisms. FASEB J. 15: 1028.
20. Irjala H., Johansson E.L., Grenman R., Alanen K., Salmi M., and Jalkanen S. 2001. Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J. Exp. Med. 194: 1033.
21. Irrthum A., Karkkainen M.J., Devriendt K., Alitalo K., and Vikkula M. 2000. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am. J. Hum. Genet. 67: 295.
22. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R.K., and Alitalo K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423.
23. Joukov V., Sorsa T., Kumar V., Jeltsch M., Claesson-Welsh L., Cao Y., Saksela O., Kalkkinen N., and Alitalo K. 1997. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16: 3898.
24. Jussila L., Valtola R., Partanen T.A., Salven P., Heikkila P., Matikainen M.T., Renkonen R., Kaipainen A., Detmar M., Tschachler E., Alitalo R., and Alitalo K. 1998. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58: 1599.
25. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V.M., Fang G.-H., Dumont D., Breitman M. and Alitalo K. 1995. Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. 92: 3566.
26. Kampmeier O.F. 1912. The value of the injection method in the study of lymphatic development. Anat. Rec. 6: 223.
27. Karkkainen M.J., Jussila L., Ferrell R.E., Finegold D.N., and Alitalo K. 2001a. Molecular regulation of lymphangiogenesis and targets for tissue oedema. Trends Mol. Med. 7: 18.
28. Karkkainen M.J., Ferrell R.E., Lawrence E.C., Kimak M.A., Levinson K.L., Alitalo K., and Finegold D.N. 2000. Missense mutations interfere with VEGFR-3 signaling in primary lymphoedema. Nat. Genet. 25: 153.
29. Karkkainen M.J., Saaristo A., Jussila L., Karila K.A., Lawrence E.C., Pajusola K., Bueler H., Eichmann A., Kauppinen R., Kettunen M.I., Yla-Herttuala S., Finegold D.N., Ferrell R.E., and Alitalo K. 2001b. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. 98: 12677.
30. Karpanen T. and Alitalo K. 2001. Lymphatic vessels as targets of tumor therapy? J. Exp. Med. 194: F37.
31. Karpanen T., Egeblad M., Karkkainen M.J., Kubo H., Ylä-Herttuala S., Jäättelä M., and Alitalo K. 2001. Vacular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61: 1786.
32. Kriehuber E., Breiteneder-Geleff S., Groeger M., Soleiman A., Schoppmann S.F., Stingl G., Kerjaschki D., Maurer D. 2001. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194: 797.
33. Kukk E., Lymboussaki A., Taira S., Kaipainen A., Jeltsch M., Joukov V., and Alitalo K. 1996. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggest a role in lymphatic vascular development. Development 122: 3829.
34. Lin Q., Lu J., Yanagisawa H., Webb R., Lyons G.E., Richardson J.A., and Olson E.N. 1998. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125: 4565.
35. Mäkinen T., Jussila L., Veikkola T., Karpanen T., Kettunen M.I., Pulkkanen K.J., Kauppinen R., Jackson D.G., Kubo H., Nishikawa S.-I., Ylä-Herttuala S., and Alitalo K. 2001a. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7: 199.
36. Mäkinen T., Veikkola T., Mustjoki S., Karpanen T., Wise L., Mercer A., Catimel B., Nice E.C., Kowalski H., Kerjaschki D., Stacker S.A., Achen M.G., and Alitalo K. 2001b. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762.
37. Mandriota S.J. and Pepper M.S. 1998. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83: 852.
38. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., Banerji S., Huarte J., Montesano R., Jackson D.G., Orci L., Alitalo K., Christofori G., and Pepper M.S. 2001. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20: 672.
39. Marconcini L., Marchio S., Morbidelli L., Cartocci E., Albini A., Ziche M., Bussolino F., and Oliviero S. 1999. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc. Natl. Acad. Sci. 96: 9671.
40. Nibbs R.J., Kriehuber E., Ponath P.D., Parent D., Qin S., Campbell J.D., Henderson A., Kerjaschki D., Maurer D., Graham G.J., and Rot A. 2001. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am. J. Pathol. 158: 867.
41. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., and Honda Y. 1999. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 274: 15732.
42. Oh S.J., Jeltsch M.M., Birkenhager R., McCarthy J.E., Weich H.A., Christ B., Alitalo K., and Wilting J. 1997. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188: 96.
43. Ohta Y., Shridhar V., Bright R.K., Kalemkerian G.P., Du W., Carbone M., Watanabe Y., and Pass H.I. 1999. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br. J. Cancer 81: 54.
44. Papoutsi M., Tomarev S.I., Eichmann A., Prols F., Christ B., and Wilting J. 2001. Endogenous origin of the lymphatics in the avian chorioallantoic membrane. Dev. Dyn. 222: 238.
45. Pennisi D., Gardner J., Chambers D., Hosking B., Peters J., Muscat G., Abbott C., and Koopman P. 2000. Mutations in Soxl 8 underlie cardiovascular and hair follicle defects in ragged mice. Nat. Genet. 24: 434.
46. Petrova T.V., Mäkinen T., Mäkelä T.P., Saarela J., Virtanen I., Ferrell R.E., Finegold D.N., Kerjaschki D., Ylä-Herttuala S., and Alitalo K. 2002. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 home box transcription factor. EMBO J. 21: 4593.
47. Plate K.H. 2001. From angiogenesis to lymphangiogenesis. Nat. Med. 7: 151.
48. Risau W. 1997. Mechanisms of angiogenesis. Nature 386: 671.
49. Risau W. and Flamme I. 1995. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11: 73.
50. Sabin F.R. 1902. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am. J. Anat. 1: 367.
51. -. 1909. The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole. Am. J. Anat. 9: 43.
52. Schneider M., Othman-Hassan K., Christ B., and Wilting J. 1999. Lymphangioblasts in the avian wing bud. Dev. Dyn. 216: 311.
53. Skobe M., Hawighoest T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., and Detmar M. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7: 192.
54. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., Jackson D.G., Nishikawa S.-I., Kubo H., and Achen M.G. 2001. Vascular endothelial growth factor-D promotes the metastatic spread of cancer via the lymphatics. Nat. Med. 7: 186.
55. Stacker S.A., Stenvers K., Caesar C., Vitali A., Domagala T., Nice E., Roufail S., Simpson R.J., Moritz R., Karpanen T., Alitalo K., and Achen M.G. 1999. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J. Biol. Chem. 274: 32127.
56. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., and McDonald D.M. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511.
57. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald K., and Yancopoulos G.D. 2000. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6: 460.
58. Thyboll J., Kortesmaa J., Cao R., Soininen R., Wang L., Iivanainen A., Sorokin L., Risling M., Cao Y., and Tryggvason K. 2002. Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol. Cell. Biol. 22: 1194.
59. Tsurusaki T., Kanda S., Sakai H., Kanetake H., Saito Y., Alitalo K., and Koji T. 1999. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br. J. Cancer 80: 309.
60. Veikkola T., Jussila L., Makinen T., Karpanen T., Jeltsch M., Petrova T.V., Kubo H., Thurston G., McDonald D.M., Achen M.G., Stacker S.A., and Alitalo K. 2001. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 20: 1223.
61. Wigle J.T. and Oliver G. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell 98: 769.
62. Wigle J.T., Harvey N., Detmar M., Lagutina I., Grosveld G., Gunn M.D., Jackson D.G., and Oliver G. 2002. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21: 1505.
63. Witte M.H., Bernas M.J., Martin C.P., and Witte C.L. 2001. Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology. Microsc. Res. Tech. 55: 122.
64. Witzenbichler B., Asahara T., Murohara T., Silver M., Spyridopoulos I., Magner M., Principe N., Kearney M., Hu J.S., and Isner J.M. 1998. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol. 153: 381.
65. Yonemura Y., Endo Y., Fujita H., Fushida S., Ninomiya I., Bandou E., Taniguchi K., Miwa K., Ohoyama S., Sugiyama K., and Sasaki T. 1999. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin. Cancer Res. 5: 1823.